Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

FARICIMAB vs FELBAMATE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

FARICIMAB vs FELBAMATE: Safety Overview

Metric FARICIMAB FELBAMATE
Total FAERS Reports 381 473
Deaths Reported 23 28
Death Rate 6.0% 5.9%
Hospitalizations 98 145
Average Patient Age 69.6 yrs 26.7 yrs
% Female Patients 51.2% 50.3%
FDA Approval Date N/A Apr 20, 2017
Manufacturer Genentech, Inc. Zydus Lifesciences Limited
Route INTRAVITREAL ORAL
Marketing Status N/A Prescription